Randomized clinical trial: pharmacokinetics and safety of multimatrix mesalamine for treatment of pediatric ulcerative colitis

Carmen Cuffari, David Pierce, Bartosz Korczowski, Krzysztof Fyderek Krzysztof, Heather Van Heusen, Stuart Hossack, Hong Wan, Alena Edwards, Patrick Martin
  • Drug Design Development and Therapy, February 2016, Dove Medical Press
  • DOI: 10.2147/dddt.s95316

Mesalamine MMX for pediatric ulcerative colitis

The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr David Montague Pierce and Dr Bartosz Korczowski